OverviewChartNewsTraderScreen

UBS Knock-Out AZN/  DE000UM7FNQ2  /

UBS Investment Bank
2024-11-14  9:54:27 PM Chg.+0.040 Bid- Ask- Underlying Strike price Expiration date Option type
2.800EUR +1.45% -
Bid Size: -		 -
Ask Size: -		 AstraZeneca PLC 93.8572 - 2078-12-31 Put
TeleTrader 02-08 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 2023-12-22 US FDA approves AstraZeneca-Ionis's medicine
TeleTrader 2022-04-14 Canada approves AstraZeneca's Evusheld
TeleTrader 2021-05-20 Japan health expert panel okays AZ, Moderna jabs
TeleTrader 2021-03-08 Italy okays AstraZeneca's vaccine for people over 65
TeleTrader 2021-01-29 Producing vaccines is a bumpy road - AZ's Soriot
TeleTrader 2021-01-29 AstraZeneca must deliver jabs from UK to EU - Von der Leyen
TeleTrader 2021-01-29 EU publishes vaccine contract with AstraZeneca
TeleTrader 2021-01-27 EU to 'defend investments' in AstraZeneca's vaccine
TeleTrader 2021-01-25 AstraZeneca's vaccine not effective in elderly people - report
TeleTrader 2021-01-24 EU to make firms respect vaccine delivery deadlines - Michel
TeleTrader 2020-12-12 AstraZeneca to acquire Alexion for $39B
TeleTrader 2020-11-23 Johnson: Months needed to perform inoculation
TeleTrader 2020-11-01 AstraZeneca's vaccine reviewed by UK regulator
TeleTrader 2020-10-26 AstraZeneca: Vaccine trial results 'encouraging'
TeleTrader 2020-10-21 Brazil says volunteer died during Oxford vaccine trial
TeleTrader 2020-10-18 We'll have more than one vaccine in 2021 - UK expert
TeleTrader 2020-10-16 Switzerland secures 5.3M doses of AstraZeneca's vaccine
TeleTrader 2020-10-14 US expands AstraZeneca treatment collaboration
TeleTrader 2020-10-07 AstraZeneca could up vaccine price in 2021 - report
TeleTrader 2020-10-02 AstraZeneca: Vaccine trial resumes in Japan
TeleTrader 2020-09-23 Fauci: By end of 2020 we'll know if vaccines effective
TeleTrader 2020-09-23 UBS: Vaccine approval in Q4 to shift stock markets
TeleTrader 2020-09-20 AstraZeneca's vaccine trial still on hold in US - company
TeleTrader 2019-12-30 FDA approves Astra Zeneca, Merck & Co. drug